Chlorite In The Treatment Of Neurodegenerative Disease

Abstract

The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 25, 2005
  • Application: Jan 25, 2005
    WO US 2005/0002469 W
  • Priority: Feb 3, 2004
    US US 54157604 P

Download Citation


Sign in to the Lens

Feedback